Home

Migraine

Read time: 3 min

Satellite symposium

CGRP antibodies can help alleviate difficult-to-treat migraine

Clinicians and researchers are continually expanding our understanding of disease mechanisms and...

Read time: 3 min

Congress highlights

If at first you don’t succeed, try another CGRP antibody for migraine prevention?

If the first monoclonal antibody targeting calcitonin gene-related peptide fails to adequately...

Read time: 2 min

Congress highlights

Headache is an early symptom of Covid-19, often with migraine features

Headache is emerging as one of the most frequent neurological symptoms of Covid-19 reported in up...

Read time: 2 min

Congress highlights

What are the links between procalcitonin and micro RNA levels and migraine?

Procalcitonin is a partial agonist of CGRP on the CGRP receptor, and together with CGRP appears to...

Read time: 2 min

Congress highlights

Why is migraine more common in women?

Migraine is twice as prevalent in women than in men.1 Estrogen is a predisposing factor with...

Read time: 3 min

Satellite symposium

Can preventive treatment lessen the functional impact of migraine?

Migraine is highly prevalent across the globe and is associated with high levels of disability and...

Read time: 2 min

Congress highlights

Preclinical pearls offer insights into migraine sex differences and sensory thresholds

Speaking at #MTIS2020, Professor Frank Porreca, University of Arizona, USA, identified recent...

Read time: 3 min

Congress highlights

Clinical pearls of migraine and cluster headache research uncovered

From a sea of research findings, Professor Messoud Ashina, University of Copenhagen, Denmark,...

Read time: 1 min

Congress highlights

What are the most common prodromal symptoms of cluster headache?

The prodromal symptoms of cluster headache might provide clues to the pathophysiology of migraine....

Read time: 2 min

Congress highlights

CGRP therapies for migraine: What have we learned since launch?

Today is a most exciting time in the migraine field given the plethora of new therapies introduced...

Read time: 2 min

Congress highlights

Brain imaging in people with migraine during a migraine attack and over 4 years

Two functional magnetic resonance imaging studies to find out what happens to the brain in patients...

Read time: 2 min

Congress highlights

Steps towards improving quality of life for patients with migraine

Is it necessary to consider both patients and treating physicians’ views when investigating...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country